Valneva SE (VALN) Non-cash Items (2020 - 2023)
Valneva SE's (VALN) quarterly Non-cash Items came in at -$25.6 million in Q1 2023, up 13.88% year-on-year from -$22.5 million in Q1 2022, and up 89.75% quarter-over-quarter from -$250.2 million in Q4 2022.
Valneva SE (VALN) Non-cash Items (2020 - 2023) Analysis & Trends
Valneva SE has disclosed Non-cash Items across 4 years of filings, most recently posting -$25.6 million for Q1 2023.
- Non-cash Items for Q1 2023 came in at -$25.6 million, up 13.88% year-over-year; the trailing twelve-month figure through Mar 2023 was -$25.6 million (up 13.88% YoY), and the FY2022 annual result was -$250.2 million, down 369.17% from the prior year.
- Non-cash Items came in at -$25.6 million for Q1 2023 at Valneva SE, up from -$250.2 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $166.6 million in Q4 2020 to a low of -$250.2 million in Q4 2022.
- The 4-year median for Non-cash Items is $9.6 million (2021), against an average of -$13.8 million.
- Across the five-year window, Non-cash Items slumped 523.12% in 2022 and grew 13.88% in 2023, its largest moves.
- Valneva SE's Non-cash Items stood at $166.6 million in 2020, then slumped by 46.09% to $89.8 million in 2021, then sank by 378.45% to -$250.2 million in 2022, then surged by 89.75% to -$25.6 million in 2023.
- The last three Non-cash Items figures came in at -$25.6 million (Q1 2023), -$250.2 million (Q4 2022), and -$190.0 million (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -25.65 Mn |
| Mar 31, 2023 | -25.65 Mn |
| Dec 31, 2022 | -250.15 Mn |
| Dec 31, 2022 | -250.15 Mn |
| Sep 30, 2022 | -189.99 Mn |
| Sep 30, 2022 | -189.99 Mn |
| Jun 30, 2022 | -106.08 Mn |
| Jun 30, 2022 | -106.08 Mn |
| Mar 31, 2022 | -29.78 Mn |
| Mar 31, 2022 | -29.78 Mn |
| Dec 31, 2021 | 89.84 Mn |
| Dec 31, 2021 | 89.84 Mn |
| Sep 30, 2021 | 44.90 Mn |
| Sep 30, 2021 | 44.90 Mn |
| Jun 30, 2021 | 103.04 Mn |
| Jun 30, 2021 | 103.04 Mn |
| Mar 31, 2021 | 58.93 Mn |
| Mar 31, 2021 | 58.93 Mn |
| Dec 31, 2020 | 166.63 Mn |
| Dec 31, 2020 | 166.63 Mn |